T
Tybourne Capital Management
Hong Kong
Overview
Tybourne Capital Management is a growth investment firm that invests in public and private companies globally. The firm has historically focused on the consumer, financials, healthcare, and TMT sectors.
Year Founded
2012
AUM
$2B
Portfolio Companies
22
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Cambridge Photon Technology | Nov 2025 | Grant | Co-investor |
| Allotera Therapeutics | Aug 2025 | Series C | Co-investor |
| Wugen | Aug 2025 | Early Funding | Co-investor |
| SkyCell | Jun 2024 | Series D | - |
| Enito Group, Inc. | Apr 2023 | Private Equity | Co-investor |
Key People
Eashwar Viswanathan Krishnan
Portfolio Manager, Managing Partner
Bosun Hau
Portfolio Manager General Partner (Tybourne Strategic Opportunities Fund)
Lindsay Campbell
Managing Director, Investor Partnerships
Lisa Kang
Investor Services Associate
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
